Amber Jones
St. Jude Children's Research Hospital(US)
Publications by Year
Research Areas
Hemoglobinopathies and Related Disorders, Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Liver Disease Diagnosis and Treatment, Iron Metabolism and Disorders
Most-Cited Works
- → The use of appropriate calibration curves corrects for systematic differences in liver R2* values measured using different software packages(2013)80 cited
- → A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload(2012)53 cited
- → A Phase 2a Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Myelofibrosis(2019)45 cited
- → A Phase 2 Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Advanced Myelofibrosis(2021)21 cited
- → Fast approximation to pixelwise relaxivity maps: Validation in iron overloaded subjects(2013)15 cited
- → A Phase 2 Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Essential Thrombocythemia (ET)(2021)13 cited
- → Cardiac R2* values are independent of the image analysis approach employed(2013)9 cited
- → S832 A PHASE 2A STUDY OF THE LSD1 INHIBITOR IMG‐7289 FOR THE TREATMENT OF MYELOFIBROSIS(2019)5 cited
- → A 3-Year-Old Boy with Severe Anemia and Neutropenia(2013)3 cited
- → Safety, Tolerability and Dose Response of FBS0701, a Novel Iron Chelator for Treatment of Transfusional Iron Overload: Results of a 24-Week Multicenter, International Phase 2 Study(2011)1 cited